SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Qazi Khaleda Rahman)
 

Search: WFRF:(Qazi Khaleda Rahman) > Mesoporous silica p...

Mesoporous silica particles potentiate antigen specific T cell responses

Kupferschmidt, Natalia (author)
Uppsala universitet,Nanoteknologi och funktionella material
Rahman Qazi, Khaleda (author)
Dept of Medicine Solna, Translational Immunology Unit, KI, Stockholm, Sweden
Kemi, Cecilia (author)
Experimental Asthma and Allergy Research, Centre for Allergy Research, The Institute of Environmental Medicine, KI, Stockholm, Sweden
show more...
Vallhov, Helen (author)
Dept of Medicine Solna, Translational Immunology Unit, KI, Stockholm, Sweden
Garcia-Bennett, Alfonso E (author)
Stockholm Univ, Dept Mat & Environm Chem, Stockholm, Sweden
Gabrielsson, Susanne (author)
Dept of Medicine Solna, Translational Immunology Unit, KI, Stockholm, Sweden
Scheynius, Annika (author)
Dept of Medicine Solna, Translational Immunology Unit, KI, Stockholm, Sweden
show less...
 (creator_code:org_t)
Future Medicine Ltd, 2014
2014
English.
In: Nanomedicine. - : Future Medicine Ltd. - 1743-5889 .- 1748-6963. ; 9:12, s. 1835-1846
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Aim: To study the adjuvant effect of mesoporous silica particles and their capability of modifying an already existing allergic Th2-like immune response. Materials & methods: The adjuvant effect of Santa Barbara Amorphous-15 (SBA-15) mesoporous silica particles was studied in an antigen-specific ovalbumin (OVA) system in vitro and in vivo. The capacity of the OVA-loaded SBA-15 particles (SBA-15-OVA) to modify an existing immune response was assessed in a murine allergy model. Results: SBA-15-OVA induced significantly stronger OVA-specific splenocyte proliferation compared with OVA alone. Significantly higher IFN-γ production was observed in ex vivo OVA-stimulated splenocytes from SBA-15-OVA-immunized mice compared with mice injected with only SBA-15 or OVA. Treatment of OVA-sensitized mice with SBA-15-OVA modified the immune response with significantly lower serum levels of OVA-specific IgE and higher IgG levels compared with the alum-OVA-treated group. Conclusion: The results are promising for the continued development of mesoporous silica materials for therapeutic applications. Original submitted 18 January 2013; Revised submitted 30 August 2013

Subject headings

TEKNIK OCH TEKNOLOGIER  -- Industriell bioteknik -- Medicinsk bioteknik (hsv//swe)
ENGINEERING AND TECHNOLOGY  -- Industrial Biotechnology -- Medical Biotechnology (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view